DMKC Advisory Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$534K Buy
+2,040
New +$523K 0.13% 61
2025
Q3
– Sell
-2,662
Closed -$509K – 76
2025
Q2
$509K Buy
2,662
+1,327
+99% +$247K 0.27% 65
2025
Q1
$280K Hold
1,335
– – 0.25% 51
2024
Q4
$237K Buy
+1,335
New +$245K 0.22% 53

Other funds holding ABBV

DMKC Advisory Services's ABBV Position: Q3 2026 in Review

DMKC Advisory Services opened a new position in AbbVie (ABBV) in Q3 2026: 2,040 shares worth $534K. The stake represents 0.13% of the portfolio and ranks #61 among its holdings. This is a return to the name: DMKC Advisory Services previously reported a position in ABBV as recently as Q2 2025.

DMKC Advisory Services first reported a position in ABBV in Q4 2024 and has held it in 4 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • DMKC Advisory Services held 2,040 shares of AbbVie worth $534K as of Q3 2026.
  • AbbVie was a new DMKC Advisory Services position in Q3 2026.
  • AbbVie made up 0.13% of DMKC Advisory Services's portfolio in Q3 2026, its #61 holding.
  • DMKC Advisory Services first reported a position in AbbVie in Q4 2024 and has held it in 4 quarters since.
  • 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on DMKC Advisory Services's 13F filing for Q3 2026, filed 4 Nov 2026.